Fewer hospital stays, lower costs seen with year’s use of Spinraza
People with spinal muscular atrophy (SMA) who are treated with Spinraza (nusinersen) are less likely to require hospitalization or emergency medical care, and hospitalization-related costs correspondingly tend to decrease after starting on the therapy, a U.S. database study reports. The study, “Evaluation of inpatient and…